Abrams Capital Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.43M | Hold |
3,811,513
| – | – | 0.12% | 12 |
|
|
2025
Q1 | $6.71M | Hold |
3,811,513
| – | – | 0.12% | 12 |
|
|
2024
Q4 | $10.1M | Hold |
3,811,513
| – | – | 0.16% | 12 |
|
|
2024
Q3 | $8.73M | Hold |
3,811,513
| – | – | 0.14% | 13 |
|
|
2024
Q2 | $11.1M | Hold |
3,811,513
| – | – | 0.22% | 13 |
|
|
2024
Q1 | $13.9M | Hold |
3,811,513
| – | – | 0.43% | 13 |
|
|
2023
Q4 | $5.76M | Hold |
3,811,513
| – | – | 0.18% | 14 |
|
|
2023
Q3 | $5.11M | Hold |
3,811,513
| – | – | 0.17% | 15 |
|
|
2023
Q2 | $6.86M | Hold |
3,811,513
| – | – | 0.2% | 16 |
|
|
2023
Q1 | $6.33M | Hold |
3,811,513
| – | – | 0.2% | 16 |
|
|
2022
Q4 | $7.32M | Hold |
3,811,513
| – | – | 0.26% | 16 |
|
|
2022
Q3 | $8.54M | Hold |
3,811,513
| – | – | 0.25% | 18 |
|
|
2022
Q2 | $12.3M | Hold |
3,811,513
| – | – | 0.33% | 17 |
|
|
2022
Q1 | $20M | Hold |
3,811,513
| – | – | 0.47% | 17 |
|
|
2021
Q4 | $32.4M | Hold |
3,811,513
| – | – | 0.71% | 16 |
|
|
2021
Q3 | $37.9M | Hold |
3,811,513
| – | – | 0.83% | 16 |
|
|
2021
Q2 | $35.5M | Hold |
3,811,513
| – | – | 0.79% | 15 |
|
|
2021
Q1 | $34M | Buy |
+3,811,513
| New | +$34M | 0.77% | 15 |
|